期刊文献+

厄洛替尼单药治疗非小细胞肺癌继发重症肺纤维化一例 被引量:4

原文传递
导出
摘要 患者男,57岁,吸烟30余年,平均每日1包。无慢性支气管炎、肺气肿病史,无放射性物质接触史。2007年2月末体检摄X线胸片时发现右下肺占位。3月初出现声音嘶哑,2007年3月21日于我院门诊查肺部增强CT见:右下肺癌伴纵隔淋巴结转移可能性大,肺气肿,双下肺轻度间质性肺炎(图1)。2007年3月23日入我科,
出处 《中华内科杂志》 CAS CSCD 北大核心 2008年第2期151-151,共1页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献4

  • 1Smith J. Erlotinib : small-molecule targeted therapy in the treatment of non-small-cell lung cancer. Clin Ther,2005,27:1513-1534.
  • 2Vahid B, Esmaili A. Erlotinib-associated acute pneumonitis: report of two cases. Can Respir J ,2007,14 : 167-170.
  • 3Tammaro KA, Baldwin PD, Lundberg AS. Interstitial lung disease following erlotinib (Tarceva) in a patient who previously tolerated gefitinib ( Iressa). J Oncol Pharm Pract,2005,11 : 127-130.
  • 4Kato T, Nishio K. Clinical aspects of epidermal growth factor receptor inhibitors : benefit and risk. Respirology, 2006,11 : 693-698.

同被引文献45

  • 1雷莉,罗继征,孟军英,宋迎新,白云,王仑,王荃,吴利群.厄洛替尼引起急性间质性肺病死亡2例[J].药物不良反应杂志,2007,9(4):277-278. 被引量:16
  • 2Dowe U J, Minna JD, Kirkpatrick P. Erlotinib hydroch- loride[ J]. Nat ReV Drug Discov,2005,4( 1 ) :13 - 14.
  • 3Tang PA,Tsao MS, Moore MJ. A review of erlotinib and its elinical use [J ]. Expert Opin Pharmacother, 2006,7 (2) :177 -193.
  • 4Silvestri GA, Rivera MP. Targeted therapy for the treatment of advanced non-small-cell lung cancer. A review of the epidermal growth factor receptor antagonists [ J ]. Chest,2005,128 (6) :3975 - 3984.
  • 5Vahid B, Esmaili A. Erlotinib-associated acute pneumonitis: Report of two cases [ J ]. Can Respir J, 2007,14(3) :167 - 170.
  • 6Chou CL, Ko HW. Erlotinib-associated near-fatal inters- titial pneumonitis in a patient with relapsed lung adenocarcinoma[ J]. Chang Gung ned J, 2010,33 (1): 100 - 104.
  • 7Makris D, Schevpereel A, Copin MC, et al. Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer[J]- BMC Cancer 2007,7:150.
  • 8Togashi Y, Masago K, Hamatani Y, et al. Successful erlotinib rechallenge for leptomeningeal metastases of lung adenocarcinoma after erlotinib-induced interstitial lung disease: A case report and review of the literature [ J ] Lung Cancer,2012,77 (2) : 464 -468.
  • 9Taj A, Kanjwal S, Hammersley JR. New-onset acute interstitial lung disease after treatment with erlotinib in a patient with metastatic squamous cell carcinoma of the lung [ J ]. Am J Ther, 2011,18 ( 1 ) : e1 9 - e21.
  • 10Hsieh CH, Chang HT, Lin SC, et al. Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment -Case report [ J ] BMC Cancer, 2010, 10:696.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部